This content is provided by Chambers. Learn more about our methodology
What the team is known for Established practice advising clients on domestic and cross-border acquisitions and divestments. Acts on a range of other transactions, including public tender offers and joint ventures. Particularly popular with clients from the life sciences and banking industries. Represents private equity funds in transactions, advising on both acquisitions and corporate exits. Also assists private individuals with the sale of shares.
Strengths Clients report that the team is "solution-oriented, flexible and helpful."
Sources also describe the lawyers as "pragmatic and constructive."
Work highlights Advised Lundbeck on the EUR905 million acquisition of Prexton Therapeutics' share capital.
Benedict Christ assists international clients from the financial sector with the divestment of Swiss subsidiaries. Interviewees report that he is good to work with, saying that he "is pragmatic and the deal went well."
Jürg Luginbühl assists private equity funds with acquisitions and corporate exits. Clients describe him as "open, communicative and pragmatic." He also advises clients from the luxury goods industry on joint ventures.
Matthias Staehelin for his work for pharmaceutical clients, particularly for start-ups and in venture capital matters. He is also noted for his experience in assisting clients from the life sciences sector with corporate transactions.
Robert Bernet acts for domestic and international clients on the acquisition of Swiss companies. Bernet recently advised on a number of transactions in the technology sector.